Filtered By:
Management: Food and Drug Administration (FDA)
This page shows you your search results in order of date. This is page number 5.
Order by Relevance | Date
Total 75 results found since Jan 2013.
The Easter Bunny Could Soon Bring Safer Candy With Natural Food Colors
Candy left by the Easter Bunny on Sunday morning comes in festive hues of blue, green, yellow and pink, sparking smiles from many kids. This brightly colored loot may be less welcome, however, to a growing number of parents who worry about the potential health hazards the colors reflect.
Could the Blue 1, Red 40 and Yellow 5 dyes, for example, found in Peeps marshmallow chicks, Whoppers Mini Robin Eggs, Jelly Belly's Kids Mix and countless other sweets harm their children?
To be safe, many like Courtney Sucato of Phoenix, are no longer taking chances with the man-made additives, which are generally derived from petrole...
Source: Science - The Huffington Post - April 4, 2015 Category: Science Source Type: news
The 5th Annual Alexander Awards: The Best Tox Reading of 2014
Alexander Gettler
The distinguished Alexander Awards go to the best writings related to toxicology topics that have appeared in the previous year. To be eligible to win an Alexander, an article or paper must be freely available on the web, not locked up behind some paywall or subject to restricted access. The awards are named for Alexander Gettler (1883-1968,) the chief toxicologist with the Office of the Chief Medical Examiner of the City of New York during the first half of the 20th century. Gettler’s work was crucial in the development of modern forensic toxicology.
In a must-read piece from New York magazine, Stev...
Source: The Poison Review - January 2, 2015 Category: Toxicology Authors: Leon Tags: Medical alexander award alexander gentler best toxicology reading 2014 Source Type: news
Shire to Test Its ADHD Drug in 4- to 5-Year-Olds in U.S.Shire to Test Its ADHD Drug in 4- to 5-Year-Olds in U.S.
Shire Plc has agreed to a U.S. Food and Drug Administration request to study its stimulant Vyvanse in preschool children as concern rises over the diagnosis and treatment of attention deficit hyperactivity disorder. Reuters Health Information
Source: Medscape Pharmacist Headlines - June 16, 2014 Category: Drugs & Pharmacology Tags: Psychiatry News Source Type: news
Shire to test its ADHD drug in 4 to 5-year olds in U.S.
WASHINGTON (Reuters) - Shire Plc SHP.L has agreed to a U.S. Food and Drug Administration request to study its stimulant Vyvanse in preschool children as concern rises over the diagnosis and treatment of attention deficit hyperactivity disorder, the drugmaker said on Thursday.
Source: Reuters: Health - June 13, 2014 Category: Consumer Health News Tags: healthNews Source Type: news
Alcobra seeks FDA's IND approval for Metadoxine extended-release to treat ADHD
Israeli biopharmaceutical company Alcobra has filed an investigational new drug (IND) application to the US Food and Drug Administration (FDA) to start a Phase III clinical trial with its proprietary drug candidate MG01CI (Metadoxine extended-release…
Source: Pharmaceutical Technology - February 10, 2014 Category: Pharmaceuticals Source Type: news
Painful Priapism, ADHD Drugs, and other News of Tox on the Web
This article is essential reading. (For more on tramadol, click here.)
[HT @DavidJuurlink]
Carbon Monoxide Toxicity: Over at Academic Life in Emergency Medicine, there is an excellent review of carbon monoxide toxicity by Dr. Dan Repplinger, with expert peer review by Dr. David Juurlink. The review focuses on the indications for hyberbaric oxygen therapy. Dr. Juurlink summation reflects my opinion on the matter exactly: ” . . .there are no absolute indications for HBO on patients with CO poisoning. Don’t let anyone tell you otherwise.” Another must-read.
Liver toxicity and dietary supplements: The New...
Source: The Poison Review - December 24, 2013 Category: Toxicology Authors: Leon Tags: Medical ADHD atomoxetine attention deficit hyperactivity disorder carbon monoxide poisoning cyanide deborah blum dietary supplements hepatotoxicity hyperbaric oxygen lead toxicity liver injury strattera tox on the web tramadol Source Type: news
Must-read: The NY Times on the marketing of ADHD drugs
This article, although it really doesn’t feature a smoking gun, is important reading. Highly recommended.
Source: The Poison Review - December 16, 2013 Category: Toxicology Authors: Leon Tags: Medical adderall ADHD attention deficit hyperactivity disorder concerta intuniv marketing new york times Ritalin Source Type: news
Psychotropic use in preschool-age children 'stabilizing'
The use of psychotropic prescription medications to treat mental health disorders in very young children is stabilizing, according to a study published in the journal Pediatrics. Psychotropic medications that are commonly prescribed to treat ADHD, mood disorders and other mental health problems include both typical and atypical antipsychotics, antidepressants, antianxiety agents, stimulants and mood stabilizers. Few of these medications have been approved for use at preschool age by the US Food and Drug Administration (FDA)...
Source: Health News from Medical News Today - September 30, 2013 Category: Consumer Health News Tags: Pediatrics / Children's Health Source Type: news
FDA accepts Neurovance's IND application for ADHD drug
The US Food and Drug Administration (FDA) has accepted Neurovance's investigational new drug (IND) application for EB-1020 SR, a norepinephrine and dopamine-preferring triple reuptake inhibitor.
Source: Drug Development Technology - September 24, 2013 Category: Pharmaceuticals Source Type: news
Brain wave monitor that claims to detect ADHD is approved for use in the U.S.
The U.S. Food and Drug Administration is now allowing marketing of the device which records electrical impulses given off by nerve cells in the brain as a way of diagnosing ADHD.
Source: the Mail online | Health - July 18, 2013 Category: Consumer Health News Source Type: news
New Class III Designation (De Novo) Summary: Neuropsychiatric EEG-Based Assessment Aid for ADHD (NEBA) System - K112711
The Food and Drug Administration Modernization Act of 1997 (FDAMA) added the "De Novo" classification option as an alternate pathway to classify certain new devices that had automatically been placed in Class III due to lack of a predicate.
Source: Food and Drug Adminstration (FDA): CDRHNew - July 18, 2013 Category: Medical Equipment Source Type: news
New ADHD Test Uses Brainwaves
A new test of brain waves measured by electroencephalogram (EEG) has been approved for helping to diagnose whether a child has attention deficit hyperactivity disorder (ADHD). The US Food and Drug Administration (FDA) today gave the green light to the NEBA System, which, "along with other clinical information, may help healthcare providers more accurately determine if ADHD is the cause of a behavioral problem," says Christy Foreman, a product evaluation director at the FDA. EEGs record electrical impulses, or waves, produced by neurons - nerve cells - in the brain...
Source: Health News from Medical News Today - July 16, 2013 Category: Consumer Health News Tags: ADHD Source Type: news
FDA approves first brain-wave test for ADHD in children and teens
The first ever brain-wave test for attention deficit hyperactivity disorder (ADHD) in children and adolescents has been approved for use by the US Food and Drug Administration.
Source: Pharmaceutical Technology - July 15, 2013 Category: Pharmaceuticals Source Type: news
FDA permits marketing of first brain wave test to help assess children and teens for ADHD
The U.S. Food and Drug Administration today allowed marketing of the first medical device based on brain function to help assess attention-deficit/hyperactivity disorder (ADHD) in children and adolescents 6 to 17 years old. When used as part of a complete medical and psychological examination, the device can help confirm an ADHD diagnosis or a clinician’s decision that further diagnostic testing should focus on ADHD or other medical or behavioral conditions that produce symptoms similar to ADHD.
Source: Food and Drug Administration - July 15, 2013 Category: American Health Source Type: news
